Infection: Ceftolozane-tazobactam gives a new ASPECT to the fight against antimicrobial resistance
- PMID: 25963963
- DOI: 10.1038/nrurol.2015.103
Infection: Ceftolozane-tazobactam gives a new ASPECT to the fight against antimicrobial resistance
Republished in
-
Urinary tract infection: Ceftolozane-tazobactam gives a new ASPECT to the fight against antimicrobial resistance.Nat Rev Nephrol. 2015 Jul;11(7):388. doi: 10.1038/nrneph.2015.77. Epub 2015 May 12. Nat Rev Nephrol. 2015. PMID: 25963590 No abstract available.
Comment on
-
Ceftolozane-tazobactam compared with levofloxacin in the treatment of complicated urinary-tract infections, including pyelonephritis: a randomised, double-blind, phase 3 trial (ASPECT-cUTI).Lancet. 2015 May 16;385(9981):1949-56. doi: 10.1016/S0140-6736(14)62220-0. Epub 2015 Apr 27. Lancet. 2015. PMID: 25931244 Clinical Trial.
References
-
- Lancet. 2015 May 16;385(9981):1949-56 - PubMed
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Medical
